Sanofi’s Q2 Earnings Show 8.1% Global Sales Growth, Led by Dupixent and China Expansion
France-based Sanofi (NASDAQ: SNY) reported Q2 2022 global sales of EUR 10.1 billion (USD 10.3...
France-based Sanofi (NASDAQ: SNY) reported Q2 2022 global sales of EUR 10.1 billion (USD 10.3...
India-based Sun Pharma has suspended the supply of its bicalutamide to Beijing, Tianjin, Jilin, Shanghai,...
The Chinese Pharmacists Association (CPA) has released the “National Volume-based Procurement (VBP) Drug Management Expert...
China’s 7th national Volume-Based Procurement (VBP) round concluded with winning bids for 60 drug products...
China’s Joint Procurement Office (JPO) announced plans on July 11 to conduct a volume-based procurement...
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
The Shanghai Medical Products Administration (SMPA) has revoked the winning bid of India-based Sun Pharmaceutical...
In a departure from previous practice, the 7th national volume-based procurement (VBP) round will not...
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...